Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Free Subscription


2 Am J Med
3 Antimicrob Agents Chemother
5 Antiviral Res
1 Biochemistry (Mosc)
17 BMJ
3 Cell
1 Eur J Epidemiol
5 J Epidemiol Community Health
2 J Exp Med
13 J Infect Dis
1 J Virol
10 Lancet
1 Lancet Child Adolesc Health
7 Lancet Gastroenterol Hepatol
18 Lancet Infect Dis
5 Lancet Oncol
1 Lancet Psychiatry
3 Lancet Public Health
10 MMWR Morb Mortal Wkly Rep
8 N Engl J Med
2 Pediatrics
1 PLoS Comput Biol
1 PLoS Med
5 PLoS One
2 Proc Natl Acad Sci U S A
4 Vaccine
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

  1. ISHACK S, Lipner SR
    Applications of 3D Printing Technology to Address COVID-19-Related Supply Shortages.
    Am J Med. 2020;133:771-773.

  2. SINGHANIA N, Bansal S, Singhania G
    An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19).
    Am J Med. 2020;133:e365-e366.

    Antimicrob Agents Chemother

  3. JEON S, Ko M, Lee J, Choi I, et al
    Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
    Antimicrob Agents Chemother. 2020;64.
    PubMed         Abstract available

  4. SOFTIC L, Brillet R, Berry F, Ahnou N, et al
    Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
    Antimicrob Agents Chemother. 2020;64.
    PubMed         Abstract available

  5. MARATHE BM, Asthagiri Arunkumar G, Vogel P, Pascua PNQ, et al
    Monoclonal Antibody Therapy Protects Pharmacologically Immunosuppressed Mice from Lethal Infection with Influenza B Virus.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00284.
    PubMed         Abstract available

    Antiviral Res

  6. CALY L, Druce JD, Catton MG, Jans DA, et al
    The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.
    Antiviral Res. 2020 Apr 3:104787. doi: 10.1016/j.antiviral.2020.104787.
    PubMed         Abstract available

  7. SHANNON A, Le NT, Selisko B, Eydoux C, et al
    Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Antiviral Res. 2020;178:104793.
    PubMed         Abstract available

  8. SALLARD E, Lescure FX, Yazdanpanah Y, Mentre F, et al
    Type 1 interferons as a potential treatment against COVID-19.
    Antiviral Res. 2020;178:104791.
    PubMed         Abstract available

  9. TANG T, Bidon M, Jaimes JA, Whittaker GR, et al
    Coronavirus membrane fusion mechanism offers as a potential target for antiviral development.
    Antiviral Res. 2020 Apr 6:104792. doi: 10.1016/j.antiviral.2020.104792.
    PubMed         Abstract available

  10. CHOY KT, Yin-Lam Wong A, Kaewpreedee P, Sia SF, et al
    Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
    Antiviral Res. 2020 Apr 3:104786. doi: 10.1016/j.antiviral.2020.104786.
    PubMed         Abstract available

    Biochemistry (Mosc)

    Molecular Targets in the Chemotherapy of Coronavirus Infection.
    Biochemistry (Mosc). 2020;85:523-530.
    PubMed         Abstract available


  12. DUONG YT, Wright CG, Justman J
    Antibody testing for coronavirus disease 2019: not ready for prime time.
    BMJ. 2020;370:m2655.

  13. SUAREZ-GONZALEZ A, Zimmermann N, Waddington C, Wood O, et al
    Non-memory led dementias: care in the time of covid-19.
    BMJ. 2020;369:m2489.

  14. SMITH CA
    Covid-19: healthcare students face unique mental health challenges.
    BMJ. 2020;369:m2491.

  15. GOH S
    Who will guard the guards? Covid-19 research may be incomplete, but experts are vital during this pandemic.
    BMJ. 2020;370:m2658.

  16. KARMAKAR S, Dhar R, Jee B
    Covid-19: research methods must be flexible in a crisis.
    BMJ. 2020;370:m2668.

  17. CASIGLIANI V, De Nard F, De Vita E, Arzilli G, et al
    Too much information, too little evidence: is waste in research fuelling the covid-19 infodemic?
    BMJ. 2020;370:m2672.

  18. KAMARA M, Bingham R
    Covid-19: unjustified risk to people held in immigration removal centres.
    BMJ. 2020;370:m2673.

    Is stratified shielding from covid-19 feasible and ethical?
    BMJ. 2020;370:m2660.

  20. ROCA M, Vicens C, Gili M
    Covid-19 and the future of mental health in primary care.
    BMJ. 2020;369:m2520.

  21. NICHOLSON TW, Talbot NP, Nickol A, Chadwick AJ, et al
    Respiratory failure and non-invasive respiratory support during the covid-19 pandemic: an update for re-deployed hospital doctors and primary care physicians.
    BMJ. 2020;369:m2446.

  22. SHELDON TA, Wright J
    Twin epidemics of covid-19 and non-communicable disease.
    BMJ. 2020;369:m2618.

  23. BENNETT P, Hunter R, Johnston S, Jones D, et al
    Covid-19: recording their stories provides emotional benefit to healthcare workers.
    BMJ. 2020;369:m2536.

  24. CHANG BP, Kessler RC, Pincus HA, Nock MK, et al
    Digital approaches for mental health in the age of covid-19.
    BMJ. 2020;369:m2541.

  25. KHASHU M
    Covid-19: scientific advisers must do more than just voice their concerns behind closed doors.
    BMJ. 2020;369:m2534.

  26. RODERICK P, Macfarlane A, Pollock AM
    Getting back on track: control of covid-19 outbreaks in the community.
    BMJ. 2020;369:m2484.

  27. SIGMAN A
    Covid-19 and alcohol: parental drinking influences the next generation.
    BMJ. 2020;369:m2525.

    Covid-19: healthcare and politics are inexorably intertwined.
    BMJ. 2020;369:m2532.


  29. GRIFONI A, Weiskopf D, Ramirez SI, Mateus J, et al
    Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
    Cell. 2020;181:1489-1501.
    PubMed         Abstract available

  30. BOST P, Giladi A, Liu Y, Bendjelal Y, et al
    Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.
    Cell. 2020;181:1475-1488.
    PubMed         Abstract available

  31. SEMPOWSKI GD, Saunders KO, Acharya P, Wiehe KJ, et al
    Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19.
    Cell. 2020;181:1458-1463.
    PubMed         Abstract available

    Eur J Epidemiol

  32. ORIVE G, Lertxundi U, Barcelo D
    Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection?
    Eur J Epidemiol. 2020;35:613-614.

    J Epidemiol Community Health

  33. LAI FTT
    Association between time from SARS-CoV-2 onset to case confirmation and time to recovery across sociodemographic strata in Singapore.
    J Epidemiol Community Health. 2020;74:678.

    Paradox of success and public perspective: COVID-19 and the perennial problem of prevention.
    J Epidemiol Community Health. 2020;74:679.

  35. KHALATBARI-SOLTANI S, Cumming RC, Delpierre C, Kelly-Irving M, et al
    Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards.
    J Epidemiol Community Health. 2020;74:620-623.
    PubMed         Abstract available

  36. BONELL C, Michie S, Reicher S, West R, et al
    Harnessing behavioural science in public health campaigns to maintain 'social distancing' in response to the COVID-19 pandemic: key principles.
    J Epidemiol Community Health. 2020;74:617-619.

  37. LEWIS P, Erren TC
    COVID-19: science must not be the boy who cried wolf.
    J Epidemiol Community Health. 2020;74:676.

    J Exp Med

  38. CASSOTTA A, Paparoditis P, Geiger R, Mettu RR, et al
    Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin.
    J Exp Med. 2020;217.
    PubMed         Abstract available

    The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.
    J Exp Med. 2020;217.
    PubMed         Abstract available

    J Infect Dis

  40. KOBAYASHI KI, Kaki T, Mizuno S, Kubo K, et al
    Clinical Characteristics of Patients With Coronavirus Disease 2019 in Japan: A Single-Center Case Series.
    J Infect Dis. 2020;222:194-197.
    PubMed         Abstract available

  41. BURBELO PD, Riedo FX, Morishima C, Rawlings S, et al
    Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:206-213.
    PubMed         Abstract available

  42. RATNESAR-SHUMATE S, Williams G, Green B, Krause M, et al
    Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces.
    J Infect Dis. 2020;222:214-222.
    PubMed         Abstract available

  43. ZENG QL, Ji F, Zhang JY
    Response to Malkovsky.
    J Infect Dis. 2020;222:510-511.

  44. NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
    Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:17-25.
    PubMed         Abstract available

  45. NIE X, Fan L, Mu G, Tan Q, et al
    Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.
    J Infect Dis. 2020;222:26-33.
    PubMed         Abstract available

  46. ZENG QL, Yu ZJ, Gou JJ, Li GM, et al
    Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:38-43.
    PubMed         Abstract available

  47. ZHANG G, Nie S, Zhang Z, Zhang Z, et al
    Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.
    J Infect Dis. 2020;222:183-188.
    PubMed         Abstract available

  48. ZHANG Y, Qin L, Zhao Y, Zhang P, et al
    Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
    J Infect Dis. 2020;222:34-37.
    PubMed         Abstract available

  49. GRAEPEL KW, Kochhar S, Clayton EW, Edwards KE, et al
    Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 May 4. pii: 5828933. doi: 10.1093.

  50. JIANG M, Guo Y, Luo Q, Huang Z, et al
    T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:198-202.
    PubMed         Abstract available

  51. CAI XF, Chen J, Li Hu J, Long QX, et al
    A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:189-193.
    PubMed         Abstract available

  52. DAWSON L, Earl J, Livezey J
    Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
    J Infect Dis. 2020;222:514-516.

    J Virol

  53. ARAI Y, Elgendy EM, Daidoji T, Ibrahim MS, et al
    H9N2 influenza virus infections in human cells require a balance between NA sialidase activity and HA receptor affinity.
    J Virol. 2020 Jul 8. pii: JVI.01210-20. doi: 10.1128/JVI.01210.
    PubMed         Abstract available


  54. CHAN EYY, Gobat N, Kim JH, Newnham EA, et al
    Informal home care providers: the forgotten health-care workers during the COVID-19 pandemic.
    Lancet. 2020 Jun 1. pii: S0140-6736(20)31254.

  55. MYLES PS, Maswime S
    Mitigating the risks of surgery during the COVID-19 pandemic.
    Lancet. 2020 May 29. pii: S0140-6736(20)31256.

  56. CHU DK, Akl EA, Duda S, Solo K, et al
    Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.
    Lancet. 2020 Jun 1. pii: S0140-6736(20)31142.
    PubMed         Abstract available

  57. MACINTYRE CR, Wang Q
    Physical distancing, face masks, and eye protection for prevention of COVID-19.
    Lancet. 2020 Jun 1. pii: S0140-6736(20)31183.

  58. MULLER JE, Nathan DG
    COVID-19, nuclear war, and global warming: lessons for our vulnerable world.
    Lancet. 2020 Jun 12. pii: S0140-6736(20)31379.

  59. TREWEEK S, Forouhi NG, Narayan KMV, Khunti K, et al
    COVID-19 and ethnicity: who will research results apply to?
    Lancet. 2020 Jun 12. pii: S0140-6736(20)31380.

  60. BURZYNSKA K, Contreras G
    Gendered effects of school closures during the COVID-19 pandemic.
    Lancet. 2020 Jun 12. pii: S0140-6736(20)31377.

  61. GABSTER BP, van Daalen K, Dhatt R, Barry M, et al
    Challenges for the female academic during the COVID-19 pandemic.
    Lancet. 2020 Jun 18. pii: S0140-6736(20)31412.

  62. GNECCHI M, Moretti F, Bassi EM, Leonardi S, et al
    Myocarditis in a 16-year-old boy positive for SARS-CoV-2.
    Lancet. 2020;395:e116.

  63. SIPIDO KR, Antonanzas F, Celis J, Degos L, et al
    Overcoming fragmentation of health research in Europe: lessons from COVID-19.
    Lancet. 2020 Jun 16. pii: S0140-6736(20)31411.

    Lancet Child Adolesc Health

    Maintaining safety and service provision in human milk banking: a call to action in response to the COVID-19 pandemic.
    Lancet Child Adolesc Health. 2020;4:484-485.

    Lancet Gastroenterol Hepatol

    Drinking alone: COVID-19, lockdown, and alcohol-related harm.
    Lancet Gastroenterol Hepatol. 2020;5:625.

  66. GUPTA N, Desalegn H, Ocama P, Lacombe K, et al
    Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa.
    Lancet Gastroenterol Hepatol. 2020;5:634-636.

  67. CHEN Y, Hu S, Wu H, Farraye FA, et al
    Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic.
    Lancet Gastroenterol Hepatol. 2020 May 13. pii: S2468-1253(20)30131.

  68. D'AMICO F, Rahier JF, Leone S, Peyrin-Biroulet L, et al
    Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey.
    Lancet Gastroenterol Hepatol. 2020 May 13. pii: S2468-1253(20)30151.

  69. MAO R, Qiu Y, He JS, Tan JY, et al
    Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.
    Lancet Gastroenterol Hepatol. 2020 May 12. pii: S2468-1253(20)30126.
    PubMed         Abstract available

  70. MAK JWY, Chan FKL, Ng SC
    Probiotics and COVID-19: one size does not fit all.
    Lancet Gastroenterol Hepatol. 2020 Apr 24. pii: S2468-1253(20)30122.

  71. MAURICE JB, Siau K, Sebastian S, Ahuja N, et al
    Green endoscopy: a call for sustainability in the midst of COVID-19.
    Lancet Gastroenterol Hepatol. 2020;5:636-638.

    Lancet Infect Dis

    Estimating case fatality rates of COVID-19.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30245.

  73. YONG SEF, Anderson DE, Wei WE, Pang J, et al
    Connecting clusters of COVID-19: an epidemiological and serological investigation.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30273.
    PubMed         Abstract available

  74. WINTER AK, Hegde ST
    The important role of serology for COVID-19 control.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30322.

  75. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30426.

    Political casualties of the COVID-19 pandemic.
    Lancet Infect Dis. 2020 Jun 11. pii: S1473-3099(20)30496.

    Stigma during the COVID-19 pandemic.
    Lancet Infect Dis. 2020;20:782.

    High COVID-19 testing rate in Portugal.
    Lancet Infect Dis. 2020;20:783.

    COVID-19 in Iran: round 2.
    Lancet Infect Dis. 2020;20:784.

  80. PETERSEN E, Koopmans M, Go U, Hamer DH, et al
    Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
    Lancet Infect Dis. 2020 Jul 3. pii: S1473-3099(20)30484.
    PubMed         Abstract available

  81. AZMAN AS, Luquero FJ
    From China: hope and lessons for COVID-19 control.
    Lancet Infect Dis. 2020;20:756-757.

  82. ZHANG J, Litvinova M, Wang W, Wang Y, et al
    Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.
    Lancet Infect Dis. 2020;20:793-802.
    PubMed         Abstract available

  83. BAUD D, Qi X, Nielsen-Saines K, Musso D, et al
    Real estimates of mortality following COVID-19 infection.
    Lancet Infect Dis. 2020 Mar 12. pii: S1473-3099(20)30195.

  84. AHMED H, Allaf M, Elghazaly H
    COVID-19 and medical education.
    Lancet Infect Dis. 2020;20:777-778.

  85. RAJGOR DD, Lee MH, Archuleta S, Bagdasarian N, et al
    The many estimates of the COVID-19 case fatality rate.
    Lancet Infect Dis. 2020 Mar 27. pii: S1473-3099(20)30244.

  86. KIM DD, Goel A
    Estimating case fatality rates of COVID-19.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30234.

  87. SPYCHALSKI P, Blazynska-Spychalska A, Kobiela J
    Estimating case fatality rates of COVID-19.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30246.

  88. JIA Z, Lu Z
    Modelling COVID-19 transmission: from data to intervention.
    Lancet Infect Dis. 2020;20:757-758.

  89. NIEHUS R, De Salazar PM, Taylor AR, Lipsitch M, et al
    Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China.
    Lancet Infect Dis. 2020;20:803-808.
    PubMed         Abstract available

    Lancet Oncol

  90. NELSON R
    Lack of protective gear disrupts oncology care.
    Lancet Oncol. 2020;21:631-632.

    Screening of gastrointestinal cancers during COVID-19: a new emergency.
    Lancet Oncol. 2020;21:e338.

  92. BUTLER J, Finley C, Norell CH, Harrison S, et al
    New approaches to cancer care in a COVID-19 world.
    Lancet Oncol. 2020;21:e339-e340.

  93. TANG LV, Hu Y
    Poor clinical outcomes for patients with cancer during the COVID-19 pandemic.
    Lancet Oncol. 2020 May 29. pii: S1470-2045(20)30311.

    Cancer detection: the quest for a single liquid biopsy for all.
    Lancet Oncol. 2020;21:733.

    Lancet Psychiatry

  95. SOMMER IE, Bakker PR
    What can psychiatrists learn from SARS and MERS outbreaks?
    Lancet Psychiatry. 2020;7:565-566.

    Lancet Public Health

  96. COLAO A, Piscitelli P, Pulimeno M, Colazzo S, et al
    Rethinking the role of the school after COVID-19.
    Lancet Public Health. 2020 May 22. pii: S2468-2667(20)30124.

  97. DAVIES NG, Kucharski AJ, Eggo RM, Gimma A, et al
    Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study.
    Lancet Public Health. 2020 Jun 2. pii: S2468-2667(20)30133.
    PubMed         Abstract available

    Unlocking UK COVID-19 policy.
    Lancet Public Health. 2020 Jun 2. pii: S2468-2667(20)30135.

    MMWR Morb Mortal Wkly Rep

  99. MARSHALL K, Vahey GM, McDonald E, Tate JE, et al
    Exposures Before Issuance of Stay-at-Home Orders Among Persons with Laboratory-Confirmed COVID-19 - Colorado, March 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:847-849.
    PubMed         Abstract available

  100. TENFORDE MW, Billig Rose E, Lindsell CJ, Shapiro NI, et al
    Characteristics of Adult Outpatients and Inpatients with COVID-19 - 11 Academic Medical Centers, United States, March-May 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:841-846.
    PubMed         Abstract available

  101. COVID-19 Outbreak Among College Students After a Spring Break Trip to Mexico - Austin, Texas, March 26-April 5, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:830-835.
    PubMed         Abstract available

  102. CALLAGHAN AW, Chard AN, Arnold P, Loveland C, et al
    Screening for SARS-CoV-2 Infection Within a Psychiatric Hospital and Considerations for Limiting Transmission Within Residential Psychiatric Facilities - Wyoming, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:825-829.
    PubMed         Abstract available

  103. NJUGUNA H, Wallace M, Simonson S, Tobolowsky FA, et al
    Serial Laboratory Testing for SARS-CoV-2 Infection Among Incarcerated and Detained Persons in a Correctional and Detention Facility - Louisiana, April-May 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:836-840.
    PubMed         Abstract available

  104. WALTENBURG MA, Victoroff T, Rose CE, Butterfield M, et al
    Update: COVID-19 Among Workers in Meat and Poultry Processing Facilities - United States, April-May 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:887-892.
    PubMed         Abstract available

  105. SANCHEZ GV, Biedron C, Fink LR, Hatfield KM, et al
    Initial and Repeated Point Prevalence Surveys to Inform SARS-CoV-2 Infection Prevention in 26 Skilled Nursing Facilities - Detroit, Michigan, March-May 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:882-886.
    PubMed         Abstract available

  106. HSU HE, Ashe EM, Silverstein M, Hofman M, et al
    Race/Ethnicity, Underlying Medical Conditions, Homelessness, and Hospitalization Status of Adult Patients with COVID-19 at an Urban Safety-Net Medical Center - Boston, Massachusetts, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:864-869.
    PubMed         Abstract available

  107. VOGT TM, Zhang F, Banks M, Black C, et al
    Provision of Pediatric Immunization Services During the COVID-19 Pandemic: an Assessment of Capacity Among Pediatric Immunization Providers Participating in the Vaccines for Children Program - United States, May 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:859-863.
    PubMed         Abstract available

  108. GROENEWOLD MR, Burrer SL, Ahmed F, Uzicanin A, et al
    Increases in Health-Related Workplace Absenteeism Among Workers in Essential Critical Infrastructure Occupations During the COVID-19 Pandemic - United States, March-April 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:853-858.
    PubMed         Abstract available

    N Engl J Med

  109. WORSHAM C, Woo J, Jena AB
    Birth Month and Influenza Vaccination in Children.
    N Engl J Med. 2020;383:184-185.

  110. UYEKI TM
    Baloxavir for Postexposure Prophylaxis against Influenza in Households.
    N Engl J Med. 2020 Jul 8. doi: 10.1056/NEJMe2022702.

  111. DE FILIPPO O, D'Ascenzo F, Angelini F, Bocchino PP, et al
    Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMc2009166.

  112. HABERMAN R, Axelrad J, Chen A, Castillo R, et al
    Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
    N Engl J Med. 2020 Apr 29. doi: 10.1056/NEJMc2009567.

  113. HARTZBAND P, Groopman J
    Physician Burnout, Interrupted.
    N Engl J Med. 2020;382:2485-2487.

  114. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Challenges of Safe Reopening.
    N Engl J Med. 2020;382:e113.

  115. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Covid-19-Related Syndrome in Children.
    N Engl J Med. 2020;383:e10.

  116. IKEMATSU H, Hayden FG, Kawaguchi K, Kinoshita M, et al
    Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.
    N Engl J Med. 2020 Jul 8. doi: 10.1056/NEJMoa1915341.
    PubMed         Abstract available


  117. HUMPHREYS KL, Myint MT, Zeanah CH
    Increased Risk for Family Violence During the COVID-19 Pandemic.
    Pediatrics. 2020;146.

  118. DENINA M, Scolfaro C, Silvestro E, Pruccoli G, et al
    Lung Ultrasound in Children With COVID-19.
    Pediatrics. 2020;146.

    PLoS Comput Biol

  119. SCARPINO SV, Scott JG, Eggo RM, Clements B, et al
    Socioeconomic bias in influenza surveillance.
    PLoS Comput Biol. 2020;16:e1007941.
    PubMed         Abstract available

    PLoS Med

    Will COVID-19 be evidence-based medicine's nemesis?
    PLoS Med. 2020;17:e1003266.

    PLoS One

  121. XU L, Bao L, Zhou J, Wang D, et al
    Correction: Genomic Polymorphism of the Pandemic A (H1N1) Influenza Viruses Correlates with Viral Replication, Virulence, and Pathogenicity In Vitro and In Vivo.
    PLoS One. 2020;15:e0235911.
    PubMed         Abstract available

  122. KRENZLIN H, Bettag C, Rohde V, Ringel F, et al
    Involuntary ambulatory triage during the COVID-19 pandemic - A neurosurgical perspective.
    PLoS One. 2020;15:e0234956.
    PubMed         Abstract available

  123. PING W, Zheng J, Niu X, Guo C, et al
    Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic.
    PLoS One. 2020;15:e0234850.
    PubMed         Abstract available

  124. SLADE CD, Reagin KL, Lakshmanan HG, Klonowski KD, et al
    Placenta-specific 8 limits IFNgamma production by CD4 T cells in vitro and promotes establishment of influenza-specific CD8 T cells in vivo.
    PLoS One. 2020;15:e0235706.
    PubMed         Abstract available

  125. CAO Z, Li T, Liang L, Wang H, et al
    Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China.
    PLoS One. 2020;15:e0234764.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  126. MULLER NF, Stolz U, Dudas G, Stadler T, et al
    Bayesian inference of reassortment networks reveals fitness benefits of reassortment in human influenza viruses.
    Proc Natl Acad Sci U S A. 2020 Jul 6. pii: 1918304117.
    PubMed         Abstract available

  127. AREVALO CP, Le Sage V, Bolton MJ, Eilola T, et al
    Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies.
    Proc Natl Acad Sci U S A. 2020 Jul 6. pii: 1920321117.
    PubMed         Abstract available


  128. SCHAEFER GO, Tam CC, Savulescu J, Voo TC, et al
    COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
    Vaccine. 2020 Jun 4. pii: S0264-410X(20)30768.
    PubMed         Abstract available

  129. MELIDOU A, Hungnes O, Pereyaslov D, Adlhoch C, et al
    Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
    Vaccine. 2020 Jul 2. pii: S0264-410X(20)30804.
    PubMed         Abstract available

  130. SU QD, Yi Y, Zou YN, Jia ZY, et al
    The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650.
    Vaccine. 2020;38:5071-5075.
    PubMed         Abstract available

  131. PAGUIO JA, Yao JS, Dee EC
    Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines, an infodemiology study.
    Vaccine. 2020 Jun 25. pii: S0264-410X(20)30855.
    PubMed         Abstract available

    Virus Res

  132. ABUSALAMAH H, Reel JM, Lupfer CR
    Pyruvate Affects Inflammatory Responses of Macrophages During Influenza A Virus Infection.
    Virus Res. 2020 Jul 4:198088. doi: 10.1016/j.virusres.2020.198088.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.